World’s first lung cancer prevention vaccine trial funded with £2.06 million to stop cancer before it starts

A groundbreaking clinical trial is underway in the UK for LungVax, an experimental vaccine designed to prevent lung cancer. This innovative approach trains the immune system to identify and eliminate early abnormal lung cells before they become tumours. Researchers are hopeful this preventative measure could significantly reduce lung cancer incidence and improve survival rates for those at high risk.